This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Immunotherapy drug development pipeline continues significant growth in 2020 despite global pandemic impact.
Cancer Research Institute goes virtual for its Immunotherapy Patient Summit Series, connecting patients and caregivers with leading experts in cancer immunotherapy.
Cancer Research Institute announces recipients of 2020 philanthropy and science awards to be presented at virtual gala, Innovators in Science and Philanthropy.
Cancer Research Institute awards $30.2 million in grants and fellowships to support basic and clinical research in immunology and cancer immunotherapy.
The Phase 2 clinical trial will analyze blood-based biomarkers versus conventional radiography for cancer patients treated with immunotherapy; findings could change direction of lung cancer treatment
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
This October for Liver Cancer Awareness Month, let’s delve into new treatments, research insights, and how we are fueling a future immune to liver cancer.
This October for Breast Cancer Awareness Month, learn about new treatments, research discoveries, and our impact on a future immune to breast cancer.